Increasing the scale of commercialization in the world markets of research results or development works of Polish companies

Project title:The commercialization of BAFASAL® product developed as a result of R&D works on target foreign markets”

The main target of the conducted project is to develop and verify the strategy of commercialization of BAFASAL® in two target foreign markets: American and Ukrainian.
BAFASAL® product is a new generation antibacterial preparation using the effects of bacteriophages (bacterial viruses) in order to inhibit the growth of selected serotypes of Salmonella bacteria in poultry. The preparation will be used as feed additive. It constitutes an alternative to antibiotics, the use of which as feed additive has been banned in the European Union since 2006.

Project funded by the National Center for Research and Development under the program GO_GLOBAL.PL

The value of the project: PLN 175 940.00
Value of the grant: PLN 149 549.00



Proteon Pharmaceuticals S.A.

ul. Tylna 3a 90-364 Lodz, POLAND

Phone: +48 502-269-383

Mobile: +48 502-678-674

Fax: +48 42-209-33-96